Government-funded long-term care bill makes progress in House of Representatives
The House Ways and Means Committee has endorsed H.R. 6561, a bill that could help private companies use government money to provide long-term care for people who are still living at home.
Members of the committee agreed to support the bill at a meeting Thursday, by a voice vote, according to Think Advisor.
President Donald Trump’s team has blocked many of the regulations and regulation drafts developed by the administration of former President Barack Obama.
H.R. 6561 — the “Comprehensive Care for Seniors Act of 2018″ bill — would require Trump’s secretary of the U.S. Department of Health and Human Services (HHS) to complete work on one set of regulations drafted by Obama’s HHS: new rules for “Program of All-Inclusive Care for the Elderly” (PACE) plans.
The National PACE Association said in a tweet Friday that it expects H.R. 6561 to come up on the House floor for a vote this week.
If the bill becomes law and takes effect as written, it would require HHS to publish final PACE regulations by Dec. 31.
Medicaid can already pay for long-term care services in nursing homes for patients who meet state income and asset requirements.
Medicare can pay for home health care services for people who need long-term care, but, traditionally, “Original Medicare” and Medicare Advantage plans have not paid for the kinds of services that frail older people and older people with disabilities may need to get through the day, such as help with shopping, preparing food, cleaning their homes, and bathing.
Read the full story at Think Advisor.
I Advance Senior Care is the industry-leading source for practical, in-depth, business-building, and resident care information for owners, executives, administrators, and directors of nursing at assisted living communities, skilled nursing facilities, post-acute facilities, and continuing care retirement communities. I Advance Senior Care editorial team and industry experts provide market analysis, strategic direction, policy commentary, clinical best-practices, business management, and technology breakthroughs.
Topics: Medicare/Medicaid , Uncategorized